Technology News and Research

RSS

Alnylam commences dosing in ALN-TTR02 Phase I clinical trial for TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.

19 Mar 2012

Hive Health Media article cites several tips to improve skin's health

Hive Health Media has recently published an article that presents several tips for those individuals who are seeking anti-aging solutions. As a cultural movement, as well as a healthcare trend, anti-aging has become a popular activity among many generations.

19 Mar 2012

RBCC's new agreement with n3D could help develop stem-cell therapies

As global demand for innovative new stem-cell therapies grows by the day, Rainbow BioSciences' new agreement with n3D Biosciences could help to bring these therapies to market faster than ever before.

19 Mar 2012

arGEN-X introduces NHance technology to create therapeutic antibodies

arGEN-X announces today the launch of NHance, its latest cutting-edge technology enabling the creation of truly differentiated human antibody therapeutics.

19 Mar 2012

East Asian BIM gene variant contributes to drug resistance in cancer

A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.

19 Mar 2012

Pfizer supports First World Congress on Healthy and Active Ageing

As an official partner of the First World Congress on Healthy Ageing, Pfizer reaffirms the company's commitment to promote healthy and active ageing at all stages of life as a basis for enhanced productivity in the Asia Pacific. Pfizer will lead a luncheon symposium today focused on the relationship between health and economic sustainability and the resulting challenges and opportunities of shifting demographics across the region.

19 Mar 2012

Westmead Hospital endorse a new medical device designed to increase blood circulation and prevent Deep Vein Thrombosis

A new medical device, the geko™, designed to increase blood circulation through neuromuscular electro–stimulation to the common peroneal nerve, has received the positive endorsement of Westmead Hospital, New South Wales, as an important new development in the prevention of Deep Vein Thrombosis (DVT).

18 Mar 2012

Japan's MHLW provides reimbursement coverage for MTWA test

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that its Microvolt T-Wave Alternans (MTWA) test received reimbursement coverage from Japan's Ministry of Health, Labor and Welfare (MHLW).

17 Mar 2012

Sysmex America announces selection to Center for Companies That Care's 2012 Honor Roll

Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, today announces its selection to Center for Companies That Care's 2012 Honor Roll, said Karen Stoneman, Vice President of Human Resources, Sysmex America.

From Sysmex America, Inc. 17 Mar 2012

Researchers report higher price tag for robotic prostatectomy surgery

In perfecting the science of medicine, advancements always face exhaustive scrutiny and opposition. Typically, these rigors focus on confirming the efficacy of a procedure or treatment to ensure it remains in the patient's best interest for healing or wellness. More recently, with heightened emphasis on government-funded healthcare, medical procedures such as robotic prostatectomy surgery for prostate cancer treatment are under fire for cost.

17 Mar 2012

Clinicians to discuss best approaches for future cancer treatment at Brainlab's radiotherapy meeting

Today clinicians from around the world will gather at the 4th Brainlab European Radiotherapy User Meeting to share their best practice and experiences in treating difficult-to-treat cancers using advanced radiotherapy.

17 Mar 2012

IMO to open new R&D center at University of Illinois

Intelligent Medical Objects, a leader in medical informatics tools, announced today that it will be opening a new research and development center on the campus of the University of Illinois.

17 Mar 2012

APN forms GPO partnership with ASDS

Aesyntix Physician Network (APN), a group purchasing organization (GPO) for dermatology and cosmetic surgery practices, and the American Society for Dermatologic Surgery (ASDS) today announced they have formed a partnership to provide ASDS members with significant savings opportunities on commonly purchased medical/surgical supplies and other products and services, including Revenue Cycle Management solutions.

17 Mar 2012

SBMT announces 2012 recipients of Pioneers in Medicine, Technology and Healthcare Policy Awards

Today, the Society for Brain Mapping & Therapeutics announced the 2012 recipients of the organization's prestigious Pioneers in Medicine, Technology, and Healthcare Policy Awards.

17 Mar 2012

DMEI chooses ifa EMR v6 as future Electronic Medical Record system

ifa united i-tech, a U.S. subsidiary of ifa Systems AG, the global leader for IT solutions in ophthalmology, announced that the Dean McGee Eye Institute (DMEI) selected ifa EMR v6 as its future Electronic Medical Record (EMR) system.

17 Mar 2012

Sanofi enters definitive agreement to acquire Pluromed

Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts.

17 Mar 2012

$Enrollment commences in MORE Registry for DBS in patients with refractory epilepsy$

Enrollment commences in MORE Registry for DBS in patients with refractory epilepsy

Medtronic, Inc. today announced that a patient from Kempenhaeghe-Heeze (The Netherlands) is the first patient to be enrolled into the MORE (MedtrOnic Registry for Epilepsy) Registry which is designed to look at the long-term efficacy, quality of life impact and safety of deep brain stimulation (DBS) in patients with refractory epilepsy.

From Medtronic 17 Mar 2012

QB3 renews and expands three-year agreement with Pfizer

The California Institute for Quantitative Biosciences (QB3) has renewed and expanded a three-year agreement with Pfizer Inc. to collaborate on research projects at the University of California with the potential to transform world-class science into better medicine.

17 Mar 2012

UAB researchers develop new vehicle to release proteins with therapeutic effects

UAB researchers developed a new vehicle to release proteins with therapeutic effects. The vehicles are known as "bacteria inclusion bodies", stable insoluble nanoparticles which are found normally in recombinant bacteria.

17 Mar 2012

Dental hygiene critical for preventing endocarditis in patients with congenital heart disease

Poor dental hygiene behaviours in patients with congenital heart disease are increasing their risk of endocarditis. Teens with congenital heart disease floss, brush and visit the dentist less than their peers. But they have healthier behaviours when it comes to alcohol, cigarettes and illicit drugs.

16 Mar 2012

Technology News and Research

Alnylam commences dosing in ALN-TTR02 Phase I clinical trial for TTR-mediated amyloidosis

Hive Health Media article cites several tips to improve skin's health

RBCC's new agreement with n3D could help develop stem-cell therapies

arGEN-X introduces NHance technology to create therapeutic antibodies

East Asian BIM gene variant contributes to drug resistance in cancer

Pfizer supports First World Congress on Healthy and Active Ageing

Westmead Hospital endorse a new medical device designed to increase blood circulation and prevent Deep Vein Thrombosis

Japan's MHLW provides reimbursement coverage for MTWA test

Sysmex America announces selection to Center for Companies That Care's 2012 Honor Roll

Researchers report higher price tag for robotic prostatectomy surgery

Clinicians to discuss best approaches for future cancer treatment at Brainlab's radiotherapy meeting

IMO to open new R&D center at University of Illinois

APN forms GPO partnership with ASDS

SBMT announces 2012 recipients of Pioneers in Medicine, Technology and Healthcare Policy Awards

DMEI chooses ifa EMR v6 as future Electronic Medical Record system

Sanofi enters definitive agreement to acquire Pluromed

Enrollment commences in MORE Registry for DBS in patients with refractory epilepsy

QB3 renews and expands three-year agreement with Pfizer

UAB researchers develop new vehicle to release proteins with therapeutic effects

Dental hygiene critical for preventing endocarditis in patients with congenital heart disease

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News